trial

A D1 Agonist For Working Memory

NCTId NCT02507206
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Completed
Enrollment 120 (actual)
Sponsored by Antonia New
Primary completion 2018-01-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Completed
Enrollment
120 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2013-04
Primary completion
2018-01-12
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
DAR 0-100A

Sponsors

Antonia NewLead Sponsor
New York State Psychiatric Institute, Washington Heights Community ServiceCollaborator
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Antonia S. New, MDPrincipal Investigator

Sites

1 total
New York, United States

Linked catalysts

1
A D1 Agonist For Working Memory — primary completion2018-01-12

Facts & assertions

4 sourced
Enrollment
120
Phase
PHASE2
Primary Completion Date
2018-01-12
Status
COMPLETED
relationships
The graph out of here
drug
DAR 0-100A
drug
lead_sponsor
Antonia New
company
collaborator
New York State Psychiatric Institute, Washington Heights Community Service
company
National Institute of Mental Health (NIMH)
company
indication
Dementia
indication
Personality Disorders
indication
Schizotypal Personality Disorder
indication
investigator
Antonia S. New, MD
person